The two Swiss associations in pharmaceutical medicine, SwAPP and SGPM, will hold their 25th anniversary Symposium on November 25th, 2020.
The topic of this year’s annual meeting is to discuss the framework of Personalized Medicine.
Personalized Medicine has already deeply influenced the development process of medicinal products and medical devices, leading to accelerated regulatory approvals. Its impact on different key stakeholders of the health care system will be tremendous.
What does tailor-made therapy mean for a hospital organization and for the individual patient? What tools and initiatives are in place to collect, share and protect sensitive data? Personalized treatment solutions by big pharma and small biotech companies offer different perspectives.
The Corona Immunitas initiative links private (corona-immunity status) with public health (decisions on vaccination, can we prevent another lock-down?).